Search Names & Symbols

With personal love and passion we work alone and analyze our favorite shares. May not be many, but they are worth it.

DISCLAIMER:

The financial and technical analycies presented on this website have not been performed by an Investment Services Company, nor have they been compiled by a certified analyst . It is simply a display and presentation of public data of Greek and foreign shares with informative and entertaining character.

Thursday, July 14, 2022

Corsair Gaming, Inc. (CRSR-NASDAQ) TOTAL ASSETS VS TOTAL LIABILITIES

 Corsair Gaming, Inc. (CRSR-NASDAQ) TOTAL ASSETS VS TOTAL LIABILITIES


Bayer to sell men’s health product Nebido™ to Grünenthal

 

Bayer to sell men’s health product Nebido™ to Grünenthal


Supports ongoing transformation of Bayer’s Pharma business to focus on key areas of future medical innovation / Transaction value of up to 500 million Euro / Closing expected by end of 2022
 
Berlin, July 14, 2022 – Bayer and Grünenthal have entered into a definitive agreement regarding the sale of Bayer’s men’s health product Nebido™ (testosterone undecanoate), for a purchase price totaling up to 500 million Euro.

Twitter to Announce Second Quarter 2022 Results

 Twitter to Announce Second Quarter 2022 Results


GAS LOG - SUSTAINABLE REPORT

READ HERE